Metabonomics in preclinical drug development

Author： Robertson Donald G   Reily Michael D   Baker J David  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.1, Iss.3, 2005-10, pp. : 363-376

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Application of metabonomics in drug development

By Keun Hector C   Athersuch Toby J  

Pharmacogenomics, Vol. 8, Iss. 7, 2007-07 ,pp. : 731-741

Future Medicine

Access to resources Recommend Favorite

A Review of: "Preclinical Drug Development"

By Keep Marcus F.  

Drug Development and Industrial Pharmacy, Vol. 33, Iss. 4, 2007-04 ,pp. : 493-493

Informa Healthcare

Access to resources Recommend Favorite

Preclinical drug development for childhood cancer

By Moreno Lucas   Chesler Louis   Hargrave Darren   Eccles Suzanne A   Pearson Andrew DJ  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 1, 2011-01 ,pp. : 49-64

Informa Healthcare

Access to resources Recommend Favorite

Recent advances in preclinical drug development in multiple sclerosis

By Hoban C.J.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 7, 1998-07 ,pp. : 831-854

Informa Healthcare

Access to resources Recommend Favorite

Positron Emitting Tracers in Pre-Clinical Drug Development

By  

Current Radiopharmaceuticals, Vol. 5, Iss. 2, 2012-04 ,pp. : 90-98

Bentham Science Publishers

Access to resources Recommend Favorite